Racura Oncology LtdASX: RAC

Impressive 40% response in Phase II Bisantrene AML Trial

Jun 16, 2020 at 12:10 AM UTC · Issued by Racura Oncology Ltd

Racura Oncology Ltd has released a press release.

View Attachment